Yamashita_2019_Eur.J.Pharmacol__172521

Reference

Title : Contribution of intestinal dipeptidyl peptidase-4 inhibition for incretin-dependent improved glucose tolerance in mice - Yamashita_2019_Eur.J.Pharmacol__172521
Author(s) : Yamashita S , Kawakami Y , Sato H , Sugitani S , Goto M , Kato N
Ref : European Journal of Pharmacology , :172521 , 2019
Abstract : Yamashita_2019_Eur.J.Pharmacol__172521
ESTHER : Yamashita_2019_Eur.J.Pharmacol__172521
PubMedSearch : Yamashita_2019_Eur.J.Pharmacol__172521
PubMedID: 31276666

Related information

Citations formats

Yamashita S, Kawakami Y, Sato H, Sugitani S, Goto M, Kato N (2019)
Contribution of intestinal dipeptidyl peptidase-4 inhibition for incretin-dependent improved glucose tolerance in mice
European Journal of Pharmacology :172521

Yamashita S, Kawakami Y, Sato H, Sugitani S, Goto M, Kato N (2019)
European Journal of Pharmacology :172521